ACRV

Acrivon Therapeutics, Inc. Common Stock

Price

$2.07

return (12m)

55.26%

p/e

-1.24

p/bv

1.06

DIVIDEND YIELD

0.00%

ACRV price

Acrivon Therapeutics, Inc. Common Stock

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ACRV

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

40.96%

3 months

29.06%

1 year

55.26%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals ACRV

Valuation

P/E

-1.24

Sector 7.65

Industry 7.65

P/BV

1.06

Sector 1.91

Industry 1.91

P/Revenue (PSR)

Sector 1.92

Industry 1.92

EV/EBITDA

Sector -630.62

Industry -630.62

EV/EBIT

Sector -7,206,132,315.43

Industry -7,206,132,315.43

P/EBITDA

-1.46

Sector -92.86

Industry -92.86

P/EBIT

-1.42

Sector -91.56

Industry -91.56

P/Total Assets

0.93

Sector 0.90

Industry 0.90

P/Net Current Assets

1.16

Sector -2.52

Industry -2.52

P/Working Capital

1.15

Sector -4,940.99

Industry -4,940.99

EPS

-1.77

Sector 0.72

Industry 0.72

BVPS

2.07

Sector 9.67

Industry 9.67

Efficiency

Gross Margin

0.00%

Sector 34.42%

Industry 34.42%

EBITDA Margin

Sector 2.06%

Industry 2.06%

EBIT Margin

Sector 0.23%

Industry 0.23%

Operating Margin

0.00%

Sector 4.20%

Industry 4.20%

Net Profit Margins

0.00%

Sector 2.40%

Industry 2.40%

Asset Turnover

Sector 0.11

Industry 0.11

Profitability

ROE

-85.65%

Sector 1.42%

Industry 1.42%

ROA

-74.91%

Sector -0.76%

Industry -0.76%

ROIC

Sector -65.52%

Industry -65.52%

Dividends

Dividend yield

0.00%

Sector 0.49%

Industry 0.49%

Payout

Sector 10.08%

Industry 10.08%

Debt

Current Ratio

7.99

Sector 1.44

Industry 1.44

Net Debt / EBITDA

Sector -109,118,343.39

Industry -109,118,343.39

Net Debt / EBIT

Sector -82.02

Industry -82.02

Net Debt / Equity

Sector -0.79

Industry -0.79

Gross Debt / Equity

Sector -0.39

Industry -0.39

Equity/Assets

0.87

Sector 0.42

Industry 0.42

Liabilities/Assets

0.13

Sector 0.52

Industry 0.52

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

45.17%

Sector -

Industry -

Fundamentals ACRV

DRAG THE FRAME TO SEE MORE DATA

ACRV Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Acrivon Therapeutics, Inc. Common Stock

Acrivon Therapeutics, Inc. Common Stock

Average Investor10 user rating

4.0 (1 people)

United States

- year

Founded:

Time since IPO - - year

-

Employees

Acrivon Therapeutics, Inc. Common Stock (United States) is listed on the Nasdaq and has a market capitalization of $92.05 million, with shareholders equity totaling $86.67 million.

The Company is listed on the [MARKET_NAME]

Over the past 12 months, Acrivon Therapeutics, Inc. Common Stock reported $- in revenue, generating net income of $-74.23 million.

Key financial metrics include a P/E ratio of -1.24, a price-to-book (P/B) ratio of 1.06, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ACRV.

Market cap

$92.05 million

Net worth

$86.67 million

$86,665,000.00

Assets

$99.09 million

$99,092,000.00

Total Shares Outstanding

41.84 million

41,841,000

Average Daily Trading Volume

$577.29 Thousand

$577,292.00

Sector

Others

Industry

Others

ACRV

ACRV revenue and profits

Financial Results ACRV

DRAG THE FRAME TO SEE MORE DATA

ACRV cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

UNH - UnitedHealth Group Incorporated

$394.67 31,55% (12M)

P/E

23.98

2.26%

ROE

14.27%

P/BV

3.42

SHEL - Shell PLC ADR

$90.87 28,85% (12M)

P/E

9.92

3.21%

ROE

14.29%

P/BV

1.42

STLA - Stellantis NV

$5.40 --43,93% (12M)

P/E

-0.59

0.00%

ROE

-35.93%

P/BV

0.21

COR - Cencora Inc.

$322.26 11,56% (12M)

P/E

23.63

0.73%

ROE

81.48%

P/BV

19.25

SSNLF - Samsung Electronics Co Ltd

$65.21 62,28% (12M)

P/E

0.00

0.00%

ROE

7,749.65%

P/BV

0.00

ALIZY - Allianz SE ADR

$51.73 --7,97% (12M)

P/E

14.28

2.63%

ROE

17.89%

P/BV

2.55

TTE - TotalEnergies SE ADR

$86.62 49,34% (12M)

P/E

7.18

4.53%

ROE

21.42%

P/BV

1.54

NSRGY - Nestle SA ADR

$97.10 7,42% (12M)

P/E

12.00

4.01%

ROE

58.05%

P/BV

6.97